ÂÜÀòÂÒÂ×

Jill Greytok is the Senior Director of Clinical Development at Hepion Pharmaceuticals. Jill also has experience as the Director, Clinical Development at ContraVir Pharmaceuticals, Inc. where Jill executed global Phase I-III clinical studies of anti-viral therapies. Prior to this, Jill worked as a Medical Science Liaison at Bristol-Myers Squibb for over 25 years. Throughout their career, Jill has been involved in oversight of clinical CRO/vendor selection, contract negotiation, and development of study protocols and other clinical documents associated with IND and CTA submissions.